breast cancer; gain-of-function; lncRNAs; mutant p53

LINC01605 Is a Novel Target of Mutant p53 in Breast and Ovarian Cancer Cell Lines

LINC01605 Is a Novel Target of Mutant p53 in Breast and Ovarian Cancer Cell Lines

TP53 is the most frequently mutated gene in human cancers. Most TP53 genomic alterations are missense mutations, which cause a loss of its tumour suppressor functions while providing mutant p53 (mut_p53) with oncogenic features (gain-of-function). …